Ceftriaxone induced hemolysis complicated by acute renal failure.
Over the last decade, second and third generation cephalosporins have been the most common drugs causing hemolytic anemia (HA). Of these cases, 20% have been attributed to ceftriaxone. The clinical presentation of ceftriaxone-induced HA is usually abrupt with sudden onset of pallor, tachypnea, cardio-respiratory arrest and shock. Acute renal failure (ARF) has been reported in 41% of such cases with a high fatality rate. We report a pediatric patient with ARF complicating ceftriaxone-induced HA who survived. Ceftriaxone is a commonly used drug, and early recognition of HA and institution of supportive care, including dialysis is likely to improve the outcome.
Kapur
Gaurav
G
Division of Nephrology and Hypertension, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, Michigan, USA. gkapur@dmc.org
Valentini
Rudolph P
RP
Mattoo
Tej K
TK
Warrier
Indira
I
Imam
Abubakr A
AA
D058186:Acute Kidney Injury / Q000139:chemically induced*; D000743:Anemia, Hemolytic / Q000139:chemically induced*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002443:Ceftriaxone / Q000009:adverse effects*; D002648:Child; D006801:Humans; D007683:Kidney Tubular Necrosis, Acute / Q000139:chemically induced; D008297:Male
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone